Skip to main content
SpringerLink
Log in

Managing impaired glucose metabolism in acromegalic subjects

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Melmed S. Acromegaly. N Engl J Med 2006, 355: 2558–73.

    Article  CAS  PubMed  Google Scholar 

  2. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004, 25: 102–52.

    Article  CAS  PubMed  Google Scholar 

  3. Ronchi CL, Varca V, Beck-Peccoz P, et al. Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors. J Clin Endocrinol Metab 2006, 91: 121–8.

    Article  CAS  PubMed  Google Scholar 

  4. Lindberg-Larsen R, Møller N, Schmitz O, et al. The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly. J Clin Endocrinol Metab 2007, 92: 1724–8.

    Article  CAS  PubMed  Google Scholar 

  5. Barkan AL, Burman P, Clemmons DR, et al. Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant. J Clin Endocrinol Metab 2005, 90: 5684–91.

    Article  CAS  PubMed  Google Scholar 

  6. Colao A, Arnaldi G, Beck-Peccoz P, et al. Pegvisomant in acromegaly: why, when, how. J Endocrinol Invest 2007, 30: 693–9.

    Article  CAS  PubMed  Google Scholar 

  7. Colao A, Auriemma RS, Galdiero M, et al. Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. J Clin Endocrinol Metab 2009, 94: 528–37.

    Article  CAS  PubMed  Google Scholar 

  8. Mazziotti G, Floriani I, Bonadonna S, Torri V, Chanson P, Giustina A. Effects of somatostatin analogs on glucose homeostasis: a meta-analysis of acromegaly studies. J Clin Endocrinol Metab 2009, 94: 1500–8.

    Article  CAS  PubMed  Google Scholar 

  9. Nathan DM, Buse JB, Davidson MB, et al; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32: 193–203.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal and Specialistic Medicine, University of Catania Medical School, Catania, Italy

    V. Pezzino & R. Vigneri

  2. Centre of Diabetology and Endocrine Diseases, Cannizzaro Hospital, Catania, Italy

    V. Pezzino & C. Sipione

  3. Division of Endocrinology, Garibaldi Hospital, Catania, Italy

    P. Tita & R. Vigneri

Authors
  1. V. Pezzino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Sipione
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Tita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Vigneri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pezzino, V., Sipione, C., Tita, P. et al. Managing impaired glucose metabolism in acromegalic subjects. J Endocrinol Invest 33, 71 (2010). https://doi.org/10.1007/BF03346553

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346553

Keywords

Search

Navigation